Literature DB >> 15541355

Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-kappaB and important for progression to multinucleated cell formation.

Naoko Kumagai1, Keita Ohno, Ryusuke Tameshige, Mitsuhiro Hoshijima, Keiichiro Yogo, Norihiro Ishida, Tatsuo Takeya.   

Abstract

C-src is known to play an essential role in osteoclastogenesis. We studied the regulatory mechanism as well as the significance of c-src induction in RANKL-induced differentiation of mouse monocytic RAW264 cells to TRAP-positive-multinucleated cells. We determined the genomic organization of the 5'-terminal region of mouse c-src. Mutational and biochemical analyses in the region 0.9 kb upstream of the transcription start site revealed that c-Fos and JNK pathways, in addition to NF-kappaB, participate in c-src induction in response to RANKL. On the other hand, when the expression of c-src was suppressed by introducing antisense src, the number of multinucleated cells formed was significantly reduced. Together, these findings show that the expression of c-src is under the control of AP-1 and NF-kappaB in the differentiation of RAW264 cells and that c-src plays an essential role at the stage of progression to multinucleated cell formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541355     DOI: 10.1016/j.bbrc.2004.10.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Analysis of the signaling pathways regulating Src-dependent remodeling of the actin cytoskeleton.

Authors:  Sabina E Winograd-Katz; Michal C Brunner; Natalia Mirlas; Benjamin Geiger
Journal:  Eur J Cell Biol       Date:  2010-08-17       Impact factor: 4.492

2.  Immune Defense Protein Expression in Highly Purified Mouse Lung Epithelial Cells.

Authors:  Meenal Sinha; Clifford A Lowell
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

3.  Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase.

Authors:  Xuanmao Jiao; Sanjay Katiyar; Manran Liu; Susette C Mueller; Michael P Lisanti; Anping Li; Timothy G Pestell; Kongming Wu; Xiaoming Ju; Zhiping Li; Erwin F Wagner; Tatsuo Takeya; Chenguang Wang; Richard G Pestell
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

Review 4.  Negative autoregulation of RANKL and c-Src signaling in osteoclasts.

Authors:  Keiichiro Yogo; Norihiro Ishida-Kitagawa; Tatsuo Takeya
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

5.  SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma.

Authors:  Roy Heusschen; Joséphine Muller; Marilène Binsfeld; Caroline Marty; Erwan Plougonven; Sophie Dubois; Nadia Mahli; Karen Moermans; Geert Carmeliet; Angélique Léonard; Frédéric Baron; Yves Beguin; Eline Menu; Martine Cohen-Solal; Jo Caers
Journal:  Oncotarget       Date:  2016-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.